ASCO 2012 Drug Development Research Professorship

Hodgkin Lymphoma focusing on reducing radiotherapy, while maintaining the highest possible cure rate

President's overview of ASCO 2012

Increased risk of breast cancer among young women treated with radiation as a child

Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival

Neoadjuvant therapy and PCR through chemotherapy prior to surgery

Advances in radiation oncology

Implementing symptom guidelines

Understanding involuntary weight loss

Potential of supplements and nutrition during cancer treatment

Effects of maternal chemotherapy on children